Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone/Naloxone vs Oxycodone in Chronic Cancer Pain with Constipation
NCT01885182Phase 3Completed
- Sponsor
- Mundipharma
- Start
- Jun 2013
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxycodone in cancer pain, opioid-induced constipation (OIC), sponsored by Mundipharma. Started Jun 2013; status: completed.
02
Drugs
oxycodone
03
Conditions
cancer painopioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT01885182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01885182.